1. OP0131 Optimal dose of tocilizumab for the treatment of giant cell arteritis: efficacy, safety, and exposure-efficacy analysis from giacta. (15th June 2017) Authors: Stone, JH; Tuckwell, K; Dimonaco, S; Klearman, M; Mallalieu, NL; Aringer, M; Blockmans, D; Brouwer, E; Cid, MC; Dasgupta, B; Rech, J; Salvarani, C; Schett, G; Schulze-Koops, H; Spiera, R; Unizony, SH; Collinson, N Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗